ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,656 | -14.8% | 19,758 | -3.7% | 0.01% | -11.1% |
| Q2 2023 | $416,497 | +8.8% | 20,507 | -2.3% | 0.01% | 0.0% |
| Q1 2023 | $382,949 | -13.8% | 20,995 | -2.3% | 0.01% | -30.8% |
| Q4 2022 | $444,206 | -20.1% | 21,480 | +1.1% | 0.01% | -71.7% |
| Q3 2022 | $556,000 | +16.1% | 21,246 | +12.5% | 0.05% | +206.7% |
| Q2 2022 | $479,000 | – | 18,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |